Evaluation of a smartphone app for patients with panic disorder with or without comorbid agoraphobia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00029090

Enrollment

Registered

2022-06-10

Start date

2021-08-04

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F41.0 F40.01 F40.00

Interventions

Group 1: App use, 8 weeks period Group 2: wait-list control

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: One of the following diagnoses: F41.0, F40.00, F40.01; informed consent; Minimum age of 18 years

Exclusion criteria

Exclusion criteria: no smartphone; intake of benzodiazepines; initiation or changes in a psychopharmacotherapy during the last 2 months; komorbid psychotic disorder; komorbid substance use disorder; comorbid chronic cardiovascular or pneumological disorders; acute suicidality; ongoing psychotherapeutic treatment; not fluid in German language

Design outcomes

Primary

Measure	Time frame
Post-Assessment 8 weeks after study intake primary outcomes: anxiety symptoms: Panic- and Agoraphobia-Scale (PAS), questionnaire quality of life: WHO-quality of life scale (WHOQOL-BREF), questionnaire perceived control: Anxiety Control Questionnaire (ACQ); questionnaire	—

Secondary

Measure	Time frame
Agoraphobic Cognitions Questionnaire, Bodily Sensations Questionnaire (Chambless et al., 1984) Beck Depression Inventory II (Beck et al., 1996) Brief Symptom Inventory (Derogatis, 1992)	—

Countries

Germany

Contacts

Public ContactSusanne Christ

Christoph-Dornier-Stiftung

panikstudie@jacobs-university.de0421 / 200 4881

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026